dr. sartor on the vision trial in mcrpc
Published 4 years ago • 268 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:24
dr. sartor on the significance of the reassure trial in mcrpc
-
1:38
dr. sartor on outcomes with 177lu-psma-617 after radium-223 in mcrpc
-
1:24
dr. sartor on mechanism of action and safety of radium-223 in mcrpc
-
![psmafore results: [177lu]lu-psma-617 in taxane-naive patients with mcrpc](https://i.ytimg.com/vi/upLVFTNeq9o/mqdefault.jpg)
10:20
psmafore results: [177lu]lu-psma-617 in taxane-naive patients with mcrpc
-
14:05
lutetium 177 psma - problems with the vision trial
-
5:28
psma imaging: vision trial with dr. scott tagawa
-
1:50
dr. gafita on sequencing 177lu-psma-617 in mcrpc
-
0:55
dr. sartor on patients in the alsympca radium-223 trial
-
40:03
psma & lutetium-177 in 2022 | eugene kwon, md | diy combat manual for beating prostate cancer part 4
-
11:01
lutetium-177: psma guided treatment | #prostatecancer | #markscholzmd | #pcri
-
10:07
new fda approved: pluvicto (lutetium-177) for advanced prostate cancer | mark scholz, md | pcri
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
1:18
dr. sartor on sipuleucel-t in crpc
-
1:25
dr. sartor on progress for the treatment of prostate cancer
-
1:08
dr. a. oliver sartor on the mechanism of action of radium-223
-
3:06
titan trial
-
1:16
dr. sartor on the implications of the analysis of sipuleucel-t in prostate cancer
-
0:51
dr. sartor on the next steps with sipuleucel-t for prostate cancer
-
4:24
emuc18: stampede trial
-
25:01
case study 1: hormone-sensitive, metastatic crpc
-
3:55
optimal treatment approaches for mcrpc
-
0:47
dr. oliver sartor discusses a new prostate cancer trial combining radium-223 and provenge